Abel Hall LLC’s Eli Lilly LLY Stock Holding History

Abel Hall LLC’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.21M	Buy	2,675 +1,257	+89%	+$1.28M	0.55%	23
2026 Q1	$1.3M	Buy	1,418 +44	+3%	+$44.6K	0.28%	47
2025 Q4	$1.48M	Buy	1,374 +535	+64%	+$512K	0.34%	37
2025 Q3	$640K	Sell	839 -282	-25%	-$210K	0.26%	59
2025 Q2	$874K	Buy	1,121 +231	+26%	+$180K	0.4%	38
2025 Q1	$735K	Sell	890 -82	-8%	-$68.2K	0.44%	32
2024 Q4	$750K	Sell	972 -68	-7%	-$56.3K	0.48%	33
2024 Q3	$921K	Buy	1,040 +36	+4%	+$32.4K	0.6%	27
2024 Q2	$909K	Buy	1,004 +11	+1%	+$8.8K	0.64%	26
2024 Q1	$772K	Buy	993 +78	+9%	+$55.5K	0.58%	29
2023 Q4	$533K	Buy	+915	New	+$534K	0.46%	34

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Abel Hall LLC's LLY Position: Q2 2026 in Review

Abel Hall LLC increased its Eli Lilly (LLY) stake by 89% in Q2 2026, buying an estimated $1.28M and bringing the position to 2,675 shares worth $3.21M. The position accounts for 0.55% of the portfolio, ranked #23.

Abel Hall LLC first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Abel Hall LLC held 2,675 shares of Eli Lilly worth $3.21M as of Q2 2026.
Abel Hall LLC bought 1,257 Eli Lilly shares in Q2 2026, an estimated $1.28M.
Eli Lilly made up 0.55% of Abel Hall LLC's portfolio in Q2 2026, its #23 holding.
Abel Hall LLC first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.